These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34130143)

  • 1. Recent trends in bioresponsive linker technologies of Prodrug-Based Self-Assembling nanomaterials.
    Nguyen A; Böttger R; Li SD
    Biomaterials; 2021 Aug; 275():120955. PubMed ID: 34130143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assembling prodrug nanotherapeutics for synergistic tumor targeted drug delivery.
    Wang Z; Chen J; Little N; Lu J
    Acta Biomater; 2020 Jul; 111():20-28. PubMed ID: 32454086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of linkers on the self-assembling and anti-tumor efficacy of disulfide-linked doxorubicin drug-drug conjugate nanoparticles.
    Wang Y; Wang X; Deng F; Zheng N; Liang Y; Zhang H; He B; Dai W; Wang X; Zhang Q
    J Control Release; 2018 Jun; 279():136-146. PubMed ID: 29655991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prodrug approaches for the development of a long-acting drug delivery systems.
    Chien ST; Suydam IT; Woodrow KA
    Adv Drug Deliv Rev; 2023 Jul; 198():114860. PubMed ID: 37160248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-assembling prodrugs.
    Cheetham AG; Chakroun RW; Ma W; Cui H
    Chem Soc Rev; 2017 Oct; 46(21):6638-6663. PubMed ID: 29019492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between the linker and polymer molecular weight of a self-assembling prodrug on the pharmacokinetics and therapeutic efficacy.
    Nguyen A; Rouhollahi E; Böttger R; Ong CY; Chao PH; Wu J; Chen Y; Li SD
    Biomater Sci; 2022 Jun; 10(12):3122-3136. PubMed ID: 35544350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supramolecular nanomedicines through rational design of self-assembling prodrugs.
    Wang H; Monroe M; Leslie F; Flexner C; Cui H
    Trends Pharmacol Sci; 2022 Jun; 43(6):510-521. PubMed ID: 35459589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-Responsive Self-Assemblies from the Designed Folic Acid-Modified Peptide Drug for Dual-Targeting Delivery.
    Wang D; Fan Z; Zhang X; Li H; Sun Y; Cao M; Wei G; Wang J
    Langmuir; 2021 Jan; 37(1):339-347. PubMed ID: 33356306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled drug delivery with nanoassemblies of redox-responsive prodrug and polyprodrug amphiphiles.
    Deng Z; Liu S
    J Control Release; 2020 Oct; 326():276-296. PubMed ID: 32682899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles as delivery carriers for anticancer prodrugs.
    Fang JY; Al-Suwayeh SA
    Expert Opin Drug Deliv; 2012 Jun; 9(6):657-69. PubMed ID: 22507134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
    Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
    Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanodelivery of a self-assembling prodrug with exceptionally high drug loading potentiates chemotherapy efficacy.
    Ren L; Ren S; Shu L; Wang Z; Shi K; Han W; Wang H
    Int J Pharm; 2021 Aug; 605():120805. PubMed ID: 34144134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of Curcumin Bioavailability Via the Prodrug Approach: Challenges and Prospects.
    Ratnatilaka Na Bhuket P; El-Magboub A; Haworth IS; Rojsitthisak P
    Eur J Drug Metab Pharmacokinet; 2017 Jun; 42(3):341-353. PubMed ID: 27683187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulus-responsive self-assembled prodrugs in cancer therapy.
    Dong X; Brahma RK; Fang C; Yao SQ
    Chem Sci; 2022 Apr; 13(15):4239-4269. PubMed ID: 35509461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supramolecular Organization of Polymer Prodrug Nanoparticles Revealed by Coarse-Grained Simulations.
    Gao P; Nicolas J; Ha-Duong T
    J Am Chem Soc; 2021 Oct; 143(42):17412-17423. PubMed ID: 34644073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
    Luo C; Sun J; Sun B; He Z
    Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zein-Paclitaxel Prodrug Nanoparticles for Redox-Triggered Drug Delivery and Enhanced Therapeutic Efficiency.
    Hou H; Zhang D; Lin J; Zhang Y; Li C; Wang Z; Ren J; Yao M; Wong KH; Wang Y
    J Agric Food Chem; 2018 Nov; 66(44):11812-11822. PubMed ID: 30339011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipidic prodrug approach for improved oral drug delivery and therapy.
    Markovic M; Ben-Shabat S; Keinan S; Aponick A; Zimmermann EM; Dahan A
    Med Res Rev; 2019 Mar; 39(2):579-607. PubMed ID: 30320896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coarse-Grained Model-Assisted Design of Polymer Prodrug Nanoparticles with Enhanced Cytotoxicity: A Combined Theoretical and Experimental Study.
    Gao P; Ha-Duong T; Nicolas J
    Angew Chem Int Ed Engl; 2024 Mar; 63(12):e202316056. PubMed ID: 38345287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailoring carrier-free nanocombo of small-molecule prodrug for combinational cancer therapy.
    Li H; Zang W; Mi Z; Li J; Wang L; Xie D; Zhao L; Wang D
    J Control Release; 2022 Dec; 352():256-275. PubMed ID: 36272660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.